H. Mitchell Perry

H. Mitchell Perry's AcademicInfluence.com Rankings

H. Mitchell Perry

Engineering

#5950

World Rank

#7238

Historical Rank

Biomedical Engineering

#487

World Rank

#497

Historical Rank

engineering Degrees

H. Mitchell Perry

Philosophy

#8160

World Rank

#11486

Historical Rank

Ontology

#94

World Rank

#105

Historical Rank

Logic

#5191

World Rank

#6570

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Why Is H. Mitchell Perry Influential?

(Suggest an Edit or Addition)

(See a Problem?)

H. Mitchell Perry's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. (1997) (933)
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. (1997) (800)
Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension (1997) (683)
Validation of a screening questionnaire for androgen deficiency in aging males. (2000) (629)
The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1984) (577)
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (1996) (573)
Early predictors of 15-year end-stage renal disease in hypertensive patients. (1995) (341)
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). (2000) (321)
Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. (1997) (305)
Evaluation of assays available to measure free testosterone. (2002) (303)
Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. (1973) (300)
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. (1994) (278)
Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. (2000) (266)
Editorial: Something about frailty. (2002) (242)
Polypharmacy and hospitalization among older home care patients. (2000) (235)
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. (1997) (190)
Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. (1985) (188)
Syndrome simulating collagen disease caused by hydralazine (Apresoline). (1954) (182)
Studies on the Control of Hypertension by Hyphex: II. Toxic Reactions and Side Effects (1953) (175)
Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. (2000) (174)
Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. (2000) (171)
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. (1998) (153)
Comparison of screening questionnaires for the diagnosis of hypogonadism. (2006) (147)
Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. (1980) (147)
I, RATIONALE AND DESIGN (1991) (136)
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. (1989) (136)
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. (1996) (136)
TRACE ELEMENTS IN HUMAN TISSUE. PART III. SUBJECTS FROM AFRICA, THE NEAR AND FAR EAST AND EUROPE (1965) (133)
Reported and measured physical functioning in older inner-city diabetic African Americans. (1999) (125)
Conference report on stroke mortality in the southeastern United States. (1998) (123)
Normal concentrations of some trace metals in human urine: changes produced by ethylenediaminetetraacetate. (1959) (117)
Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. (2007) (114)
Cardiovascular actions of cadmium at environmental exposure levels. (1982) (113)
Testosterone and frailty. (1997) (112)
Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. (1997) (112)
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2001) (110)
Something About Frailty (2002) (105)
Longitudinal changes in serum 25-hydroxyvitamin D in older people. (1999) (104)
Androgen deficiency in aging men: role of testosterone replacement therapy. (2000) (90)
Androgen deficiency in aging men. (1999) (89)
Studies on the Control of Hypertension: VIII. Mortality, Morbidity, and Remissions During Twelve Years of Intensive Therapy (1966) (87)
Renin‐Angiotensin‐Aldosterone System During Chronic Thiazide Therapy of Benign Hypertension (1968) (86)
Aging and bone metabolism in African American and Caucasian women. (1996) (84)
Androgens and women at the menopause and beyond. (2003) (81)
Renal venous renin in hypertension. (1970) (79)
Increase in the systolic pressure of rats chronically fed cadmium (1979) (77)
The systolic hypertension in the elderly program (1994) (75)
INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. (1995) (74)
Studies on the Control of Hypertension by Hyphex: I. Effects on Blood Pressure (1953) (73)
Transmural movements of zinc, manganses, cadmium and mercury by rat small intestine. (1967) (72)
Variation in the concentration of cadmium in human kidney as a function of age and geographic origin. (1961) (72)
Variability in the metal content of human organs. (1962) (69)
Elevated systolic pressure following chronic low-level cadmiun feeding. (1977) (63)
The effect of treatment on mortality rates in severe hypertension; a comparison of medical and surgical regimens. (1958) (60)
Lesions resembling vitamin B complex deficiency and urinary loss of zinc produced by ethylenediamine tetra-acetate. (1957) (55)
Studies on the Control of Hypertension: VI. Some Evidence for Reversal of the Process During Hexamethonium and Hydralazine Therapy (1956) (55)
Validation of salivary testosterone as a screening test for male hypogonadism (2006) (51)
Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. (2010) (49)
Hypertension and associated cardiovascular abnormalities induced by chronic barium feeding. (1989) (48)
Effects of antihypertensive medications on quality of life in elderly hypertensive women. (1994) (46)
Andropause: an old concept in new clothing. (2003) (46)
The biology of cadmium. (1976) (46)
Hypertension and tissue metal levels following intravenous cadmium, mercury, and zinc. (1970) (45)
Uptakes of zinc, manganese, cadmium and mercury by intact strips of rat intestine. (1966) (43)
Leptin, adipose tissue and aging--is there a role for testosterone? (1999) (43)
Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. (1982) (41)
Hypertension and tissue metal levels after intraperitoneal cadmium, mercury, and zinc. (1971) (40)
Hormone Replacement Therapy and Fractures in Older Adults (2001) (39)
The influence of chronic low-level cadmium and/or lead feeding on myocardial contractility related to phosphorylation of cardiac myofibrillar proteins. (1980) (39)
Relationship of age and calcitonin gene-related peptide to postprandial hypotension (1996) (38)
Effectiveness and Costs of Veterans Affairs Hypertension Clinics (1994) (37)
The endocrinology of aging. (1999) (37)
Pulmonary disease following chronic chemical ganglionic blockade; a clinical and pathologic study. (1957) (37)
Increase in the blood pressure of rats chronically fed low levels of lead. (1988) (36)
Cardiac physiologic and tissue metabolic changes following chronic low-level cadmium and cadmium plus lead ingestion in the rat. (1983) (36)
Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers--a cross-sectional study. (2006) (36)
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. (1991) (36)
Determination of cadmium in blood and urine by graphite furnace atomic absorption spectrophotometry. (1975) (35)
Guidelines for the treatment of hypertension. (1989) (34)
In vitro Production and Inhibition of Aortic Vasoconstriction by Mercuric, Cadmium, and Other Metal Ions.∗ (1967) (32)
CHLORTHALIDONE AND SERUM CHOLESTEROL (1977) (32)
Antihypertensive efficacy of treatment regimens used in Veterans Administration hypertension clinics. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. (1998) (31)
Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazine. (1955) (30)
Renin and erythropoietin in normotensive and in hypertensive patients. (1968) (29)
Cardiovascular dysfunction and hypersensitivity to sodium pentobarbital induced by chronic barium chloride ingestion. (1985) (29)
Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury. (1974) (29)
Psychosis apparently produced by reserpine. (1955) (28)
Mechanisms of the acute hypertensive effect of intra-arterial cadmium and mercury in anesthetized rats. (1967) (27)
Altered metabolism and function of rat heart following chronic low level cadmium/lead feeding. (1980) (26)
Pretreatment blood pressure as a predictor of 21-year mortality. (2000) (26)
Cadmium and lead effects on myocardial function and metabolism. (1980) (25)
Testosterone, aging and quality of life. (2005) (24)
Does cadmium contribute to human hypertension. (1983) (24)
Hypertension following Chronic, Very Low Dose Cadmium Feeding 1 (1977) (24)
Effects of reduction in drugs or dosage after long-term control of systemic hypertension. (1989) (24)
Anorexia of aging, leptin, and the Mini Nutritional Assessment. (1999) (24)
Inhibition of cadmium-induced hypertension in rats. (1980) (24)
Treatment of mild hypertension. Preliminary results of a two-year feasibility trial. (1977) (23)
Clonidine (Catapres): a new antihypertensive agent. (1970) (22)
Regional differences in mortality during 15-year follow-up of 11,936 hypertensive veterans. (1994) (22)
Antinatriuretic Effect of Intramuscular Cadmium in Rats 1 (1971) (22)
Studies on the Control of Hypertension by Hyphex: V. Effects on the Course of the Malignant Stage (1954) (21)
Electrocardiographical, Biochemical and Morphological Effects of Chronic Low Level Cadmium Feeding on the Rat Heart (1978) (21)
Intravenous diazoxide therapy in hypertensive crisis. (1977) (21)
Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience. (1986) (21)
Sodium retention in rats with cadmium-induced hypertension. (1981) (20)
Effects of 'Stroke‐Belt' residence, screening blood pressure and personal history risk factors on all‐cause mortality among hypertensive veterans (1994) (20)
Erectile dysfunction: etiology and treatment in young and old patients. (2003) (20)
Effect of a second metal on cadmium-induced hypertension. (1983) (19)
Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women. (1994) (19)
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents. (1983) (18)
Possible mechanisms of the hydralazine-related lupus-like syndrome. (1981) (17)
Mild hypertension: To treat or not to treat. Concluding remarks. (1978) (17)
Clinical program for screening and treatment of hypertension in veterans. (1982) (17)
Difficulties in diagnosing hypertension: implications and alternatives. (1992) (17)
Antihypertensive effects of metal binding agents. (1955) (17)
Effect of recent alcohol intake on parathyroid hormone and mineral metabolism in men. (1998) (16)
Effect of recent alcohol intake on parathyroid hormone and mineral metabolism in men. (1998) (16)
Age-related osteoporosis. (1994) (15)
Studies on the Control of Hypertension. VII. Effects of Ganglionic Blockade Combined With Hydralazine on the Malignant Stage Complicated by Renal Azotemia (1956) (15)
TRACE ELEMENTS IN HUMAN TISSUE. 3. SUBJECTS FROM AFRICA, THE NEAR AND FAR EAST AND EUROPE. (1965) (15)
The effects of season and alcohol intake on mineral metabolism in men. (1999) (15)
The effects of season and alcohol intake on mineral metabolism in men. (1999) (15)
The impact of pharmacist interventions on the inappropriate use of acid-suppression therapy. (2011) (15)
Dissociation of Circulating Renin and Erythropoietin in Rats (1968) (15)
Elevated circulating renin activity in rats following doses of cadmium known to induce hypertension. (1973) (14)
Pressor substances in arterial hypertension. V. Chemical and pharmacological characteristics of pherentasin. (1955) (14)
Multivariate cost-effectiveness analysis: an application to optimizing ambulatory care for hypertension. (1995) (13)
Effect of diet on increases in systolic pressure induced in rats by chronic cadmium feeding. (1982) (13)
Angiotensin-infusion test. Correlation with renin activity in peripheral venous blood. (1968) (13)
Possible relationships between the physical environment and human hypertension: cadmium and hard water. (1974) (12)
CROSS-SECTIONAL AND LONGITUDINAL ANALYSIS OF AGE-ASSOCIATED CHANGES IN BODY COMPOSITION OF MALE BROWN NORWAY RATS : ASSOCIATION OF SERUM LEPTIN LEVELS WITH PERIPHERAL ADIPOSITY. COMMENTARY. AUTHORS' REPLY (1999) (12)
Evaluation of bioassay for urinary catechol amines with strips of rabbit aorta. (1960) (12)
Editorial Facets of Femoral Fracture (2000) (12)
Part 1: Rationale and Design (1991) (11)
Elevated cadmium concentration in emphysematous lungs. (1973) (10)
Trace elements in human tissue. I. Methods. (1963) (10)
Department of Veterans Affairs hypertension meeting : a proposal for improved care. (2000) (10)
43 – Review of Hypertension Induced in Animals by Chronic Ingestion of Cadmium (1976) (10)
Trace-metal concentrations in normal human liver: methods to cope with marked variability. (1978) (9)
Use of Minoxidil in the Azotemic Patient (1980) (9)
Neurological manifestations after antihypertensive therapy with mecamylamine. (1957) (8)
The use of pentolinium tartrate with and without hydralazine in the treatment of severe hypertension. (1955) (8)
Multiple reactions to antihypertensive agents during treatment of malignant hypertension. (1962) (7)
Survival rates in severe hypertension intensively treated with hydralazine and ganglionic blockade (1960) (7)
Associations among the Mini Nutritional Assessment instrument, dehydration, and functional status among older African Americans in St. Louis, Mo., USA. (1999) (7)
Possible influence of heavy metals in cardiovascular disease: introduction and overview. (1980) (7)
CARCINOMA AND HYDRALAZINE TOXICITY IN PATIENTS WITH MALIGNANT HYPERTENSION. (1963) (7)
The antihypertensive properties of some mercaptans and other sulfur-containing compounds. (1955) (6)
Screening for Vitamin D Deficiency in Black Americans: Comparison of Total, Free, Bioavailable 25 Hydroxy Vitamin D Levels with Parathyroid Hormone Levels and Bone Mineral Density (2018) (6)
Survival in hydralazine-treated hypertensive patients with and without late toxicity. (1977) (6)
Serum fructosamine and obesity. (1999) (6)
Effect of desferrioxamine on trace metals in rat organs. (1968) (6)
Minoxidil and improvement of renal function in uremic malignant hypertension. (1980) (6)
Reversal of cadmium-induced hypertension by D-myo-inositol-1,2,6-trisphosphate. (1989) (6)
The effect of patient education on calcium intake in elderly men at risk for osteoporosis. (2005) (5)
Veterans Administration cooperative studies of hypertension. (1978) (5)
Facets of femoral fracture. (2000) (5)
Therapy of severe hypertension complicated by renal failure. (1962) (5)
The Treatment of Hypertension with Modern Drugs (1956) (5)
University of California, Davis, conference: Mild hypertension. (1988) (5)
EFFECTS OF INHIBITORS AND ACCELERATORS ON INTESTINAL ABSORPTION OF DIVALENT TRACE METALS (1971) (4)
Particular Mantle Dynamics Induced by Continental Roots (2004) (4)
Current status of therapy in hypertension. (1956) (4)
Use of Diuretics in Treatment of Hypertension in the Elderly (2012) (4)
Survival of treated hypertensive patients as a function of compliance and control. (1984) (4)
Systolic hypertension in the elderly program (SHEP). I, Rationale and design (1991) (4)
Trace Elements Related to Cardiovascular Disease (1971) (3)
Minerals in cardiovascular disease. (1973) (3)
Peptides, memory, food intake and aging (1997) (3)
Management of the postmenopausal woman with hypertension. Case presentation and panel discussion. (1985) (2)
Six-Year Compliance with a Treatment Regimen and Resultant Control of Blood Pressure in Special Veterans Administration Hypertension Clinics (1986) (2)
The evolution of antihypertensive therapy. (1985) (2)
Lifelong Management of Hypertension (1983) (2)
Chemistry and pharmacology of 1-hydrazinophthalazine (1954) (2)
Disturbances of the internal environment and their correction. (1953) (1)
Errors in evaluation of the severity of hypertension. (1956) (1)
Complications of hypertension and their relation to therapy (1983) (1)
Update on multicenter clinical trials in hypertension (1993) (1)
A Proposal for Improved Care (2000) (1)
DuringChronic Thiazide Therapy ofBenignHypertension (1968) (0)
The routine hypertensive work-up. (1972) (0)
The Systolic Hypertension in the Elderly Program (SHEP): Rationale, Design, Recruitment, and Baseline Data (1989) (0)
Volume Contents (2004) (0)
Uniformity and constancy of the pressor effect induced in rats by low dose cadmium feeding (1988) (0)
The medical control of hypertension. (1953) (0)
Multicenter hypertension trials: past, present, and future (1990) (0)
Mild hypertension: to treat or not to treat. Introduction. (1978) (0)
Mild hypertension--when and how to treat it. (1982) (0)
Hypertension in man and animals as an asymptomatic manifestation of long-term low-level lead exposure (1986) (0)
Pilot Study of the Systolic Hypertension in the Elderly Program Type of event ICD number Outline of criteria for event Hypertensive Stroke Left ventricular failure Transient ischemic attack Atherosclerotic Myocardial infarction Sudden death Angina pectoris Coronary artery surgery (2005) (0)
Ascertainment system for morbidity and mortality follow-up of SHEP participants (1984) (0)
Effects of Transition Metals and of Metal-Binding Antihypertensive Agents on Tryptamine Oxidase and Dopa Decarboxylase∗ (1969) (0)
MEDICAL management of hypertension. (1963) (0)
The enigma of mild hypertension: how much treatment? (1983) (0)
P047: Effects of birthplace and geographic variation in disease (1998) (0)
Medical Management of Hypertension (1963) (0)
Current Use of Ambient and Biological Monitoring: Reference Workplace Hazards. Inorganic Toxic Agents — Cadmium II (1984) (0)
Cardiovascular diseases related to geochemical environment. Hypertension and the geochemical environment. (1972) (0)
PRESSOR SUBSTANCES IN ARTERIAL HYPERTENSION (1955) (0)
Effect of aging on bone mass and bone metabolism in native American women (1998) (0)
Hexamethonium chloride and 1-hydrazinophthalazine (hyphex) in malignant hypertension (1954) (0)
Systolic hypertension in the elderly program (SHEP) pilot study: Predictors of cardiovascular (CV) events (1986) (0)
Vasodilators and their association with remission (1983) (0)

This paper list is powered by the following services:

H. Mitchell Perry's Academic­Influence.com Rankings

Why Is H. Mitchell Perry Influential?

H. Mitchell Perry's Published Works

Published Works

H. Mitchell Perry's AcademicInfluence.com Rankings